Lisata Therapeutics, Inc. (LSTA)

NASDAQ: LSTA · IEX Real-Time Price · USD

3.550

0.00 (0.00%)

At close: Jul 19, 2024, 4:00 PM

3.440

-0.110 (-3.10%)

Pre-market: Jul 22, 2024, 8:25 AM EDT

Lisata Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1995
Market Capitalization	29	22	20	50	28	26	Upgrade
Market Cap Growth	-0.14%	11.75%	-60.48%	81.39%	6.25%	-25.50%	Upgrade
Enterprise Value	-14	-28	-49	-45	-7	1	Upgrade
PE Ratio	-	-1.07	-0.37	-1.83	-3.40	-1.35	Upgrade
PB Ratio	0.69	0.46	0.30	0.55	0.85	1.25	Upgrade
P/FCF Ratio	-1.37	-1.11	-0.93	-2.26	-3.14	-1.38	Upgrade
P/OCF Ratio	-1.37	-1.11	-0.94	-2.26	-3.14	-1.38	Upgrade
EV/EBITDA Ratio	0.76	1.23	0.87	1.54	0.36	-0.05	Upgrade
EV/EBIT Ratio	0.75	1.22	0.87	1.54	0.36	-0.05	Upgrade
EV/FCF Ratio	0.92	1.41	2.30	2.00	0.77	-0.05	Upgrade
Quick Ratio	8.13	7.67	10.85	21.00	9.86	4.21	Upgrade
Current Ratio	8.92	8.18	11.26	21.27	10.08	4.35	Upgrade
Return on Equity (ROE)	-39.70%	-37.90%	-70.10%	-27.10%	-26.90%	-70.00%	Upgrade
Return on Assets (ROA)	-35.90%	-34.50%	-65.90%	-26.00%	-23.70%	-56.80%	Upgrade
Return on Capital (ROIC)	-59.23%	-53.39%	-86.52%	-31.49%	-58.91%	-96.52%	Upgrade
Earnings Yield	-68.00%	-93.79%	-272.69%	-54.59%	-29.38%	-74.17%	Upgrade
FCF Yield	-63.96%	-90.15%	-107.90%	-44.33%	-31.88%	-72.33%	Upgrade
Buyback Yield / Dilution	-3.84%	-55.85%	-40.46%	-258.27%	-49.54%	-6.56%	Upgrade
Total Shareholder Return	-3.84%	-55.85%	-40.46%	-258.27%	-49.54%	-6.56%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).